Last reviewed: June 5, 2026
Last updated: June 5, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Women considering pregnancy while on GLP-1 therapy face an important medical decision: continuing treatment offers metabolic benefits, but reproductive safety data remains limited. The American College of Obstetricians and Gynecologists recommends discontinuing GLP-1 medications three months before attempting conception, though individual timelines depend on your health profile and treatment goals.
What Current Research Shows About GLP-1 and Pregnancy
Clinical trials for semaglutide and tirzepatide have not included pregnant women or those actively trying to conceive. Reproductive toxicology studies in animals have not shown structural birth defect signals at standard doses, but long-term human pregnancy data does not exist. This absence of evidence is not evidence of safety—it simply means the medical community lacks the detailed human trial data needed to confidently recommend GLP-1 use during pregnancy.
Weight loss itself improves fertility outcomes in women with obesity, increasing ovulation rates and reducing miscarriage risk. However, the specific role of GLP-1 medications in supporting or hindering pregnancy has not been thoroughly studied in human populations. Your doctor must weigh the benefits of continued weight management against the unknown risks of medication exposure during a critical fetal development window.
Timing Your GLP-1 Pause Before Conception
Most reproductive endocrinologists recommend stopping GLP-1 therapy three months before you plan to try for pregnancy. This three-month washout allows the medication to clear your system and gives your body time to stabilize hormonal patterns that may have been influenced by GLP-1 treatment. During this waiting period, focus on maintaining the weight loss you have achieved through diet, exercise, and behavioral changes that formed the foundation of your GLP-1 therapy.
If you become pregnant unexpectedly while taking semaglutide or tirzepatide, contact your prescribing doctor and obstetrician immediately. They can review your specific dose, treatment duration, and health factors to assess any potential exposure risk. Many unplanned exposures result in healthy pregnancies, but professional medical guidance tailored to your situation is essential for peace of mind and proper monitoring.
How Weight Loss Improves Your Fertility Prospects
Obesity reduces fertility through multiple pathways: insulin resistance disrupts ovulation, excess estrogen from fat tissue alters hormone balance, and inflammatory markers interfere with egg quality and implantation. Losing five to ten percent of body weight can restore regular menstrual cycles, increase pregnancy rates, and lower miscarriage risk—benefits that appear independent of which weight loss method you use. This means the work you do with GLP-1 therapy before pausing treatment may have already significantly improved your reproductive potential.
Women who achieve their weight loss goals on GLP-1 and then maintain that loss through lifestyle changes often experience better fertility outcomes than those who never lose weight. Your PlexusDx provider can help you transition from medication-supported weight loss to sustainable maintenance strategies designed to support your fertility timeline. Genetic factors identified through the Precision Peptide Genetic Test can also guide whether your body responds better to specific nutritional or activity patterns during your conception-planning phase.
Discussing Pregnancy Plans with Your GLP-1 Provider
Bring your fertility timeline to every appointment with your PlexusDx provider or prescribing physician. Sharing that you plan to try for pregnancy in six months, one year, or longer allows your doctor to create a personalized discontinuation schedule and monitor your weight stability in the months after pausing treatment. Your provider can also assess whether other health conditions—such as polycystic ovary syndrome, thyroid dysfunction, or metabolic syndrome—require treatment adjustments as you prepare for conception.
Ask your doctor about bridging strategies to maintain weight loss after stopping GLP-1, including structured meal plans, exercise programs, and behavioral coaching. Some providers recommend continuing dietary support, accountability check-ins, or even lower-dose therapy temporarily if you experience significant weight rebound during the three-month washout period. Proactive communication between you, your GLP-1 provider, and your obstetrician ensures a coordinated approach that protects both your fertility goals and your metabolic health.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Is it safe to take semaglutide or tirzepatide while trying to get pregnant?
Current medical guidelines recommend stopping GLP-1 medications three months before attempting conception due to limited pregnancy safety data. Although animal studies have not shown birth defects, human trial data in pregnant women does not exist. PlexusDx recommends discussing your specific fertility timeline with your doctor to create a personalized discontinuation plan that protects your reproductive health.
Will stopping GLP-1 cause me to regain all the weight I lost?
Weight regain after stopping GLP-1 varies widely depending on diet, exercise, and individual metabolism. Many patients maintain 50-70% of their initial weight loss if they continue the behavioral habits developed during treatment. Your PlexusDx provider can help design a maintenance strategy including structured meal plans and activity guidance to stabilize your weight during the pregnancy-planning phase.
Can the Precision Peptide Genetic Test help me plan for pregnancy while managing my weight?
Yes. PlexusDx's Precision Peptide Genetic Test identifies your genetic response patterns across 14 metabolic pathways and 49 peptides, revealing whether your body responds optimally to GLP-1 therapy and how well you maintain weight loss through lifestyle changes alone. These insights help your provider design a post-medication maintenance plan tailored to your genetic predispositions, supporting stable weight during your conception timeline.
How much will PlexusDx semaglutide cost during my pregnancy planning phase?
Compounded semaglutide injection starts at $149 per month and remains flat regardless of dose adjustments. PlexusDx serves all 50 states without insurance requirements or membership fees, and treatments are HSA/FSA eligible. Your dose may need to go up. Your price won't—making it affordable to work with your provider on a customized weight management strategy before pausing treatment.
What should I tell my obstetrician about my past GLP-1 use?
Inform your obstetrician of the specific medication (semaglutide or tirzepatide), your treatment duration, the maximum dose you reached, and when you stopped taking it. Provide details about how much weight you lost and whether you have maintained that loss. This complete history helps your OB assess your metabolic health, past medication exposure if pregnancy occurs, and nutritional needs to support both you and a developing fetus.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
How Much Ozempic Can You Take for Weight Loss?
How Much Weight Can You Lose Per Week on Ozempic?